Lancet. 1978 Mar 18;1(8064):569-71.
Analyses of the frequency of reporting of rheumatoid arthritis have been undertaken as part of the continuing major prospective survey of oral contraceptives. The rate of reporting in oral-contraceptive users (takers) is half of the rate in non-users (controls). The rates for ex-takers and controls are not materially different. The expected rise in the rate of reporting in women over 35 is apparent in controls but suppressed in takers. In the absence of any accountable bias, it is concluded that oral contraceptives protect against the development of rheumatoid arthritis. Although the effect is small, the observation may be valuable in understanding the aetiology of the disease and the mechanism of action of oral contraceptives.
作为口服避孕药持续进行的大型前瞻性调查的一部分,已对类风湿性关节炎的报告频率进行了分析。口服避孕药使用者(服用者)的报告率是非使用者(对照组)的一半。既往服用者和对照组的报告率没有实质性差异。35岁以上女性报告率的预期上升在对照组中很明显,但在服用者中受到抑制。在没有任何可解释偏差的情况下,得出的结论是口服避孕药可预防类风湿性关节炎的发生。尽管这种效果很小,但这一观察结果可能有助于理解该疾病的病因和口服避孕药的作用机制。